MiRNA Scientific
PrivateLast Round
Buyout/LBO
Jun 18, 2024
Company Overview
MiRNA Scientific is a precision healthcare company that develops non-invasive liquid biopsy urine tests for the detection, classification, and monitoring of urological cancers.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
liquid biopsyprostate cancer testprecision diagnosticsliquid biopsy testmolecular diagnosticssmall non-coding RNAsncRNAurologic oncologycancer screeningrisk stratificationnon-invasive testingcancer biomarkerbiotechdiagnostic platformurine-based test
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MiRNA Scientific Comparables
Compare MiRNA Scientific with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bio-Techne Corporation | 85% | |
| LynxDx | 85% | |
| PanGIA Biotech, Inc. | 84% | |
MiRNA Scientific Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Jun 18, 2024 | ||||
| Early Funding | Feb 26, 2018 |
MiRNA Scientific Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MiRNA Scientific's valuation, stock price, and market status.